Fibrin D-Dimer, Haemostatic Factors and Peripheral Arterial Disease

Summary

Several haemostatic factors have been shown to have a predictive role in cardiovascular disease, although their relationship with prevalent peripheral arterial disease is not well reported. Using a random sample of 1592 men and women aged 55-74 years from Edinburgh, Scotland, we examined the relationship of von Willebrand factor (vWF), tissue plasminogen activator (t-PA) and fibrin D-dimer antigens and factor VII activity to peripheral arterial disease. t-PA antigen and fibrin D-dimer showed significant linear trends of increased levels with increasing severity of disease in both sexes (p ≤0.01) and vWF showed a similar pattern in men only (p ≤0.01). On multivariate analysis, fibrin D-dimer was independently related to the risk of intermittent claudication (p ≤0.01) and, among men, to the extent of arterial narrowing in the lower limb, as measured by the ankle brachial pressure index, (ABPI) (p ≤0.001). These results are further evidence of a role for intravascular fibrin deposition in the development of peripheral atherosclerosis.

• References

• 1 Meade TW, Chakrabarti R, Haines AP, North WR S, Stirling Y, Thompson SG. Haemostatic function and cardiovascular death; early results of a prospective study. Lancet 1980; 1: 1050-1054
• 2 Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a metaanalysis and review of the literature. Ann Intern Med 1993; 118: 956-963
• 3 Banerjee AK, Pearson J, Gilliland EL, Goss D, Lewis JD, Stirling Y, Meade TW. A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants. Thromb Haemost 1992; 68: 261-263
• 4 Fowkes FG R, Lowe GD O, Housley E, Rattray A, Rumley A, Elton RA, MacGregor IR, Dawes J. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993; 342: 84-86
• 5 Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991; 66: 351-355
• 6 Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-1168
• 7 Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan D. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 940-943
• 8 Smith FB, Lowe GD O, Fowkes FG R, Rumley A, Rumley AG, Donnan PT, Housley E. Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. Atherosclerosis 1993; 102: 155-162
• 9 Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-1079
• 10 Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men Arterioscler Thromb 1994; 14: 54-59
• 11 Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO 1962; 27: 645-648
• 12 Lowe GD O, Fowkes FG R, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993; 87: 1915-1920
• 13 Fowkes FG R, Housley E, Cawood EH H, Macintyre CC A, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384-392
• 14 Lowe GD O, Wood DA, Douglas JT, Riemersma RA, Macintyre CC A, Takase I, Tuddenham EG D, Forbes CD, Elton RA, Oliver MF. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb Haemost 1991; 65: 339-343
• 15 Fowkes FG R. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol 1988; 17: 201-207
• 16 Cucuianu MP, Missits I, Olinic N, Roman S. Increased ristocetin-cofactor in acute myocardial infarction: a component of the acute phase reaction. Thromb Haemost 1980; 43: 41-44
• 17 Christe M, Fritschi J, Lammle B, Tran TH, Marbet GA, Berger W, Duckert F. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy. Thromb Haemost 1984; 52: 138-143
• 18 Folsom AR, Wu K, Shahar E, Davis CE. Association of haemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb 1993; 13: 1829-1836
• 19 Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, Gabrielli L, Lombardi B, Specchia G, Tavazzi L, Tremoli E, Della Volpe A. Polli E and the PLAT Study Group. The PLAT Study: A multidisciplinary study of haemostatic function and conventional risk factors in vascular disease patients Atherosclerosis 1991; 90: 109-118
• 20 Meade TW, Howarth DJ, Cooper J, MacCallum PK, Stirling Y. Fibrinolytic activity and arterial disease. Lancet 1994; 343: 1442
• 21 Olofssen BO, Dahlen G, Nilsson TK. Evidence for increased levels of plasminogen activator and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J 1989; 10: 77-82
• 22 Lassila R, Peltonen S, Lepantolo M, Saarinen O, Kauhanen P, Manninen V. Severity of peripheral arteriosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb 1993; 13: 1738-1742
• 23 Al-Zahrani H, Lowe GD O, Douglas JT, Cushieri R, Pollock JG, Smith WC S. Increased fibrin turnover in peripheral arterial disease: comparison with a population study. Clin Hemorheol 1992; 12: 867-872
• 24 Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE. Fibrin and fibrinogen- related antigens in patients with stable and unstable coronary artery disease. N Engl J Med 1987; 317: 1361-1365
• 25 Meade TW. Epidemiology of atheroma, thrombosis and ischaemic heart disease. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EG D. (eds) Haemostasis and Thrombosis 3rd ed, volume 2. Churchill Livingstone; London: 1994. pp 1199-1227
• 26 Smith EB, Keen GA, Grant A, Stirk C. Fate of fibrinogen in human arterial intima. Arteriosclerosis 1990; 10: 263-275
• 27 Thompson WD, Smith EB. Atherosclerosis and the coagulation system. J Pathol 1989; 159: 097-106